Engineered MSCs with Fe-Core@CMC Nanoparticles for Culture Adaptation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing mesenchymal stem cell (MSC) culture systems face challenges in efficiently promoting cellular adaptation to the culture microenvironment, limiting their expansion and differentiation, which hampers their application in regenerative medicine and drug development.

Innovation Solution

Engineered mesenchymal stem cells (MSCs) are developed by incorporating Fe-core nanoparticles coated with a cellulose shell, specifically ZVI@CMC nanoparticles, to enhance cellular adaptation and proliferation, using a method involving the preparation of a nanoparticle forming solution, addition of a reducing agent, and incubation in a magnetic field.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional MSC culture systems are used, then MSCs can be maintained in culture, but they fail to adapt to the culture microenvironment, limiting their expansion and differentiation

Engineering Contradiction:
Improvecellular adaptation to culture microenvironmentVSAvoidMSC expansion and differentiation
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent introduces Fe-core nanoparticles coated with cellulose shell (CMC) as an intermediary substance that mediates between the MSCs and the culture microenvironment. These nanoparticles are internalized by MSCs and act as a bridge to improve cellular adaptation, thereby resolving the contradiction between adaptability and productivity in culture systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the physical and chemical parameters of the culture system by introducing nanoparticles with specific properties (Fe-core with cellulose coating, specific size range, surface functional groups). These parameter changes enhance MSC adaptation and promote expansion and differentiation, simultaneously improving both adaptability and productivity.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If MSCs are expanded ex vivo, then regenerative potential is maintained, but poor adaptability to culture microenvironment prevents massive expansion

Engineering Contradiction:
Improveregenerative potentialVSAvoidmassive expansion of MSCs
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The Fe-core@CMC nanoparticles serve as a mediator that enables massive MSC expansion while preserving regenerative potential. The nanoparticles are internalized by MSCs and create a favorable intracellular environment that supports both large-scale proliferation and maintenance of differentiation capacity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent uses composite nanoparticles combining Fe-core (providing magnetic properties and structural stability) with cellulose coating (providing biocompatibility and cellular recognition). This composite structure enables simultaneous achievement of massive expansion and preserved regenerative potential through enhanced cellular uptake and reduced cytotoxicity.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered MSCs exhibit improved proliferation and differentiation capabilities, facilitating their use in treating or preventing regenerative diseases through targeted administration to specific sites, enhancing their therapeutic potential.

Implementation Method 1

a) incubating the MSC with an effective amount of the at least one nanoparticle to obtain the engineered MSCs

Methodology Applied
Scientific EffectEndocytosis:

Implementation Method 2

a-2) adding reducing agent into the nanoparticle forming solution to obtain at least one nanoparticle

Methodology Applied
Scientific EffectReduction: Reduction

Data Source

PatentUS20250325593A1Engineered mesenchymal stem cell and its use thereof
Publication Date: 2025.10.23 NAT CHENG KUNG UNIV
  • US20250325593A1 patent drawing
  • US20250325593A1 patent drawing
  • US20250325593A1 patent drawing

AI summary

The present invention provides an engineered mesenchymal stem cell (MSC), comprising: a mesenchymal stem cell; and at least one nanoparticle, retained in the MSC, wherein each nanoparticle comprises: a Fe-core and a shell coated on the Fe-core, and the shell has at least one of a hydroxyl group, a carbonyl group and an ether group. Besides, the present invention also provides a method for treating or preventing regenerative disease, comprising: administering an engineered mesenchymal stem cell to a subject in need thereof, wherein the engineered mesenchymal stem cell comprising: a mesenchymal stem cell (MSC); and at least one nanoparticle, retained in the MSC, wherein each nanoparticle comprises: a Fe-core and a shell coated on the Fe-core, and the shell has at least one of a hydroxyl group, a carbonyl group and an ether group.